External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Macula Society 2026

We will be contributing to topics related to
-
03:20 PM
Duration 5mins San Diego, USA
Real-World Steroid Utilization in Anti-VEGF–Treated DME From 2018 to 2023: A Retrospective Claims Analysis
Clement Chan, J. Fernando Arevalo, Manuel Amador, Nicole G. Bonine, Stella Ko, Achal Patel, Alexandra Warter, Carlos Medina
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:35 PM
Duration 5mins San Diego, USA
Impact of Continuous Delivery via the PDS on Nonperfusion and Vascular Leakage in Eyes With Diabetic Retinopathy or Diabetic Macular Edema
Awh C, Manjot G, Balaratnasingam C, Couturier A, Emanuelli A, Suner I, Dakouras A, Latkany P, Plenty A, Gune S
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:40 PM
Duration 5mins San Diego, USA
Retinal Fluid, Thickness Fluctuations, and Vascular Leakage in Study Eyes Treated with PDS vs Fellow Eyes Treated with Anti-VEGF Injections in Patients With Bilateral Diabetic Macular Edema in the Pagoda Trial
Jason Hsu, Eichenbaum D, Graff JM, Hsieh YT, Udaondo P, Wirthlin RS, Bobbala A, Gune S, Heinrich D, Jones M, Lin A, Santhanakrishnan A
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:45 PM
Duration 5mins San Diego, USA
RHONE-X Extension Study: Clinical Improvements in Eyes With DME Switched From Aflibercept to Faricimab▼
Colin Tan, Roger Goldberg, Ian Pearce, Veeral Sheth, Arshad Khanani, Cheryl Jones, Kara Gibson, Timothy Lai, Patricio Schlottmann, Matthew Starr, Dawn Sim
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:37 PM
Duration 5mins San Diego, USA
Greater Anatomical Improvements With Faricimab▼ vs Aflibercept 2 mg 4 and 8 Weeks After Injections in Treatment-Naïve nAMD: A TENAYA/LUCERNE Post Hoc Analysis
Manjot K. Gill, Varun Chaudhary, Avni Finn, Nicholas Dagincourt, Shriji Patel, Philippe Margaron
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:42 PM
Duration 5mins San Diego, USA
Vision Gains With Faricimab▼ vs Aflibercept 2 mg in Patients With Treatment-Naïve nAMD Who Had Small Lesions: A TENAYA/LUCERNE Post Hoc Analysis
Eric Nudleman, Nicholas Dagincourt, Florie Mar, Shriji Patel, Philippe Margaron
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:47 AM
Duration 5mins San Diego, USA
Four-Year Outcomes of Faricimab▼ in nAMD: Safety and Efficacy Results From the AVONELLE-X Long-Term Extension Trial
John A. Wells, Shriji Patel, Arshad M. Khanani, Marta S. Figueroa, Robyn Guymer, Timothy Y. Y. Lai, Andrew Lotery, Patricio Schlottmann, Veeral Sheth, Charles C. Wykoff, Ruobing Bai, Philippe Margaron, Yannan Tang, Aachal Kotecha
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:10 PM
Duration 5mins San Diego, USA
Robust Vision Gain and Anatomic Improvement With Faricimab▼ in Patients With Polypoidal Choroidal Vasculopathy: Week 48 Results From SALWEEN
Jae Hui Kim, Gemmy Cheung, Shih-Jen Chen, Tomohiro Iida, Adrian Hock Chuan Koh, Junyeop Lee, Won Ki Lee, Xiaorong Li, Paisan Ruamviboonsuk, Xiaodong Sun, Yasuo Yanagi, Ruobing Bai, Anh Nguyen Duc, Philippe Margaron, Timothy Y. Y. Lai
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:20 PM
Duration 5mins San Diego, USA
Reduction in Subretinal Hyperreflective Material (SHRM) Volume With Faricimab▼ vs Aflibercept 2 mg in Treatment-Naïve nAMD: A TENAYA/LUCERNE Post Hoc Analysis
Jesse Jung, Isabel Bachmeier, Anh Nguyen Duc, Lei Han, Andreas Maunz, Shriji Patel, Siqing Yu, Philippe Margaron, Srinvas Sadda
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:35 PM
Duration 5mins San Diego, USA
Up to 7-Year Efficacy, Macular Atrophy, and Safety of the Port Delivery Platform With Ranibizumab in Patients With nAMD: Results from the Portal Extension Trial
Pieramici D, Awh C, Graff J, Khanani A, Kitchens J, Mittra R, Regillo C, Gune S, Le Pogam S, Singh N, Thanei GA
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:50 PM
Duration 5mins San Diego, USA
Global Real-World Data With Faricimab▼ in nAMD and DME: The VOYAGER Study
Steffen Schmitz-Valckenberg, Parravano M, Bailey C, Chaikitmongkol V, Chaudhary V, Chi G, Downey A, Finger R, Ishida S, Kardatzke D, Koh A, Lövestam-Adrian M, Luna Pinto J, Schweitzer J, Sheth V, Souied E, Guymer R
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:55 PM
Duration 5mins San Diego, USA
Two-Year Real-World Clinical Outcomes in Patients With Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration Treated With Faricimab▼ in the US: The FARETINA Study
Durga Borkar, Ali F, Bonine N, Ko S, Zwick E, Toth J, Leng T, Singh R
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:00 PM
Duration 5mins San Diego, USA
Effectiveness and Safety of Faricimab▼ in Eyes With DME or nAMD Over 2 Years: Results From the UK Faricimab▼ Real-World Evidence (FARWIDE) Study
Sobha Sivaprasad, Peto T, Reynolds R, Bailey C, Downey L, Pearce I, Kiire C, De Salvo G, Varma D, Talks J, Patel P, De Silva S, Gale R, McKibbin M, Chi G, Darnell A, Downey A, Dodds M, Dayal P
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:50 PM
Duration 5mins San Diego, USA
Efficacy and Safety of Vamikibart in Patients With Uveitic Macular Edema: Anatomical Outcomes at Week 16 in the Phase 3 MEERKAT and SANDCAT Trials
Rahul Khurana, Carlos Pavesio, Nisha Acharya, Koh-hei Sonoda & Eric Suhler. Steeples L, Brittain C , Fauser S, Galloway D, Haskova Z, Harrell E, Mesquida M, Silverman D.
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:07 PM
Duration 5mins San Diego, USA
Reduced Hard Exudates and Microaneurysms With Faricimab▼ Compared With Aflibercept in YOSEMITE/RHINE Using Automated Segmentation of DME Lesions on Color Fundus Photography
Andreas Pollreisz, Prethy Rao, Christina Dinah, Laura Kunze, Michael Pircher, Elisabeth Brunner, Dawn A. Sim, Ming Yang, Acner Camino Benech, Kara Gibson, Fethallah Benmansour
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon